Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer.
about
Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib.Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cellsDesmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.A role for caveolin-1 in desmoglein binding and desmosome dynamics.Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.Possibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinomaA pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysisMatrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenograftsRecurrent head and neck cancer: current treatment and future prospects.Dermal Lipogenesis Inhibits Adiponectin Production in Human Dermal Fibroblasts while Exogenous Adiponectin Administration Prevents against UVA-Induced Dermal Matrix Degradation in Human SkinPhase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor.Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells.Development of targeted therapy for squamous cell carcinomas of the head and neck.Carfilzomib and oprozomib synergize with histone deacetylase inhibitors in head and neck squamous cell carcinoma models of acquired resistance to proteasome inhibitors.Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagy.The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas.Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.Mammalian Plakins, Giant Cytolinkers: Versatile Biological Functions and Roles in Cancer.Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
P2860
Q34294361-943B088E-55C2-4CE4-B0E6-431C0599360AQ35099053-F4DAB76F-62CD-41D2-A5C3-488C977109C5Q35099880-01771A0D-5E30-4B6D-B7B4-65CB34D8DFB1Q35529018-1CD50DCD-8CA5-47F5-9BB8-BF681CEC440BQ35587217-0A86D380-CD63-4950-A285-96571378663CQ36012652-5F899A43-26C7-497D-965A-632F842EB857Q36330529-9422AA20-B264-4D89-A56E-324E1F9706A3Q36725116-A029DC18-1D8B-4193-AF4B-808BF0FF1CC3Q36747200-D9C0C394-2A66-4430-9DB5-5003C598F145Q37118936-8A266D17-1E63-4812-AAB1-AF5573F36F62Q37134641-089B15D7-0A20-4935-B69B-97FFC0F9B3E8Q37222615-3379BE85-88A6-43CC-972A-C2EDCAACC514Q37414098-753D7B16-7C91-4E04-941C-D20B2961D04FQ37854706-1546529A-B91A-49D5-A9E7-0C96383A887AQ38986185-BDB7BAA4-FD76-4CD1-9E25-DABC1BBB1E43Q39289240-B914CE9D-8E56-4036-BF46-2AAADABB7A0FQ39776300-39D48805-5BB3-4DD2-BFE0-55C5CD6E7B7AQ39819746-03637F00-3007-46DD-9ABB-88CDC5E4F7B8Q39970394-DEE3CF5C-C6DC-4574-98BA-B8248EB768EBQ51150179-32081CBD-4257-400E-90E2-3484A68695A7Q52627612-098E8510-2C92-4DEB-8AEF-CC6FE8F94133Q52679106-68821B49-1A5F-44F0-906A-ECB5AACCB366Q53080643-E5685ECB-22E5-4874-A92A-ED6B4530303F
P2860
Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@ast
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@en
type
label
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@ast
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@en
prefLabel
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@ast
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@en
P2093
P1433
P1476
Bortezomib inhibits cell-cell ...... death in squamous cell cancer.
@en
P2093
Hans-Joachim Schmoll
Jochen H Lorch
Tarita O Thomas
P304
P356
10.1158/0008-5472.CAN-06-2162
P407
P577
2007-01-01T00:00:00Z